Attendo AB (publ) (ATT.ST)

SEK 51.8

(1.77%)

EBITDA Summary of Attendo AB (publ)

  • Attendo AB (publ)'s latest annual EBITDA in 2023 was 3.11 Billion SEK , up 40.09% from previous year.
  • Attendo AB (publ)'s latest quarterly EBITDA in 2024 Q3 was 1.03 Billion SEK , up 32.86% from previous quarter.
  • Attendo AB (publ) reported an annual EBITDA of 2.17 Billion SEK in 2022, up 0.66% from previous year.
  • Attendo AB (publ) reported an annual EBITDA of 2.16 Billion SEK in 2021, up 84.02% from previous year.
  • Attendo AB (publ) reported a quarterly EBITDA of 1.03 Billion SEK for 2024 Q3, up 32.86% from previous quarter.
  • Attendo AB (publ) reported a quarterly EBITDA of 741 Million SEK for 2024 Q1, up 7.86% from previous quarter.

Annual EBITDA Chart of Attendo AB (publ) (2023 - 2011)

Historical Annual EBITDA of Attendo AB (publ) (2023 - 2011)

Year EBITDA EBITDA Growth
2023 3.11 Billion SEK 40.09%
2022 2.17 Billion SEK 0.66%
2021 2.16 Billion SEK 84.02%
2020 1.1 Billion SEK -37.84%
2019 1.92 Billion SEK 99.46%
2018 2.02 Billion SEK -23.63%
2017 1.06 Billion SEK 9.98%
2016 1.13 Billion SEK -0.09%
2015 1.05 Billion SEK 24.5%
2014 950.4 Million SEK -1.32%
2013 858.8 Million SEK 5.26%
2012 873.8 Million SEK 14.0%
2011 757 Million SEK 0.0%

Peer EBITDA Comparison of Attendo AB (publ)

Name EBITDA EBITDA Difference
Ambea AB (publ) 2.28 Billion SEK -36.563%
Humana AB (publ) 457 Million SEK -581.619%
ProstaLund AB (publ) -16.57 Million SEK 18896.766%